Autoimmune Disease Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	150 Pages	Fortune Business Insights Pvt. Ltd.	November, 2024	FOB19302764

Best Price Guarantee
Price	from $4,850
Length	150 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	November, 2024
SKU	FOB19302764

Growth Factors of Autoimmune Disease Testing Market

The autoimmune disease testing market size was valued at USD 5.08 billion in 2022, and the market is now projected to grow from USD 5.56 billion in 2023 to USD 11.29 billion by 2030, exhibiting a CAGR of 10.7% during the forecast period of 2023-2030.

The combination of decreased patient visits to hospitals for tests and impaired testing rates resulted in the COVID-19 pandemic being a negative factor for autoimmune disease testing market. Healthcare initial and definitive care was inadequate for conditions other than COVID-19, impacting the availability of auto-immune disease patients for admission. These factors each and together contributed to the growth decline of the market in the period of the pandemic.

The bodily auto immunized diseases including rheumatoid arthritis, scleroderma, inflammation bowel diseases etc are emerging as a major issue in developed as well as in development countries across the world. These include environmental factors, genetic factors hormonal factors and immunological factors. Such increasing prevalence is now demanding the use of suitable diagnostic methods with proper therapies in the health sector.

Autoimmune diseases are difficult to diagnose primarily due to their multifaceted symptoms: the identification of an autoimmune disease can entail invasive and agonizing tests. To this end, the authors developed an approach using artificial intelligence (AI) to distinguish between PsA, RA, and healthy joints based on experiments conducted by researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen. They concluded that AI has a better potential of classifying arthritis thus faster and more precise treatments for the patients can be determined. It points out the crucial importance of the research in new diagnostic techniques that are not invasive.

Comprehensive Analysis of Autoimmune Disease Testing Market

The autoimmune disease testing market growth is rising at an exponential rate due to its market segmentation. This market expansion rightly presents a detailed local analysis based on the forces such as supply and demand which define the industry. These segmentations are methodically segregated by product type analysis, by disease type analysis, by test type analysis, and by end-user analysis. By product type analysis include reagents & consumables and instruments. By disease type analysis include rheumatoid arthritis, systemic lupus erythematosus, scleroderma, vasculitis, inflammatory bowel disease, and others. By test type analysis include antinuclear autoantibody, rheumatoid factor, C-reactive protein, anti-thyroglobulin antibody, and others. By end-user analysis include hospital & clinics, diagnostic centers, and others.

The North America region lead the autoimmune disease testing market share by benefitting a market size of USD 2.24 billion in 2022 due to adoption of technologically advanced autoimmune disease testing kits in the region.

The top players have a significant responsibility in the packaging industry for confirming industrial prospectus growth and determining the market trends. These players include F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Abbott, Werfen, Trinity Biotech, Bio-Rad Laboratories, Inc. these market players provide a level-playing competitive landscape.

In July 2023, F. Hoffmann-La Roche Ltd. introduced Elecsys HCV Duo a board consisting of diagnostic tests for use in detecting antigen and antibodies aiding the country in its fight against hepatitis C.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2030

Base Year 2022

Estimated Year 2023

Estimated Year 2023

Forecast Period 2023-2030

Historical Period 2019-2021

Growth Rate CAGR of 10.7% from 2023 to 2030

Unit Value (USD billion)

Segmentation By Product Type

Instruments

Reagents & Consumables

By Disease Type

Rheumatoid Arthritis

Systemic Lupus Erythematosus

Scleroderma

Vasculitis

Inflammatory Bowel Disease

Others

By Test Type

Antinuclear Autoantibody

Rheumatoid Factor

C-Reactive Protein

Anti-Thyroglobulin Antibody

Others

By End-user

Hospital & Clinics

Diagnostic Centers

Others

By Region

North America (the U.S. and Canada)

Europe (U.K., Germany, France, Italy, Spain, and the Rest of Europe)

Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific)

Rest of the World

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Prevalence of Key Autoimmune Diseases, By Key Countries/Regions, 2022; 4.2. New Product Launches, By Key Players; 4.3. Key Industry Developments -Mergers, Acquisitions and Partnerships; 4.4. Technological Advancements in Testing Products; 4.5. Impact of COVID-19 on the Market
5. Global Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2019-2030: 5.1. Market Analysis, Insights and Forecast – By Product Type; 5.1.1. Instruments; 5.1.2. Reagents & Consumables; 5.2. Market Analysis, Insights and Forecast – By Disease Type; 5.2.1. Rheumatoid Arthritis (RA); 5.2.2. Systemic Lupus Erythematosus (SLE); 5.2.3. Scleroderma; 5.2.4. Vasculitis; 5.2.5. Inflammatory Bowel Disease (IBD); 5.2.6. Others; 5.3. Market Analysis, Insights and Forecast – By Test Type; 5.3.1. Antinuclear Autoantibody (ANA); 5.3.2. Rheumatoid Factor (RF); 5.3.3. C-Reactive Protein (CRP); 5.3.4. Anti-Thyroglobulin Antibody (ATA); 5.3.5. Others; 5.4. Market Analysis, Insights and Forecast – By End User; 5.4.1. Hospital & Clinics; 5.4.2. Diagnostic Centers; 5.4.3. Others; 5.5. Market Analysis, Insights and Forecast – By Region; 5.5.1. North America; 5.5.2. Europe; 5.5.3. Asia Pacific; 5.5.4. Latin America; 5.5.5. Middle East & Africa
6. North America Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2019-2030: 6.1. Market Analysis, Insights and Forecast – By Product Type; 6.1.1. Instruments; 6.1.2. Reagents & Consumables; 6.2. Market Analysis, Insights and Forecast – By Disease Type; 6.2.1. Rheumatoid Arthritis (RA); 6.2.2. Systemic Lupus Erythematosus (SLE); 6.2.3. Scleroderma; 6.2.4. Vasculitis; 6.2.5. Inflammatory Bowel Disease (IBD); 6.2.6. Others; 6.3. Market Analysis, Insights and Forecast – By Test Type; 6.3.1. Antinuclear Autoantibody (ANA); 6.3.2. Rheumatoid Factor (RF); 6.3.3. C-Reactive Protein (CRP); 6.3.4. Anti-Thyroglobulin Antibody (ATA); 6.3.5. Others; 6.4. Market Analysis, Insights and Forecast – By End User; 6.4.1. Hospital & Clinics; 6.4.2. Diagnostic Centers; 6.4.3. Others; 6.5. Market Analysis, Insights and Forecast – By Country; 6.5.1. U.S.; 6.5.2. Canada
7. Europe Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2019-2030: 7.1. Market Analysis, Insights and Forecast – By Product Type; 7.1.1. Instruments; 7.1.2. Reagents & Consumables; 7.2. Market Analysis, Insights and Forecast – By Disease Type; 7.2.1. Rheumatoid Arthritis (RA); 7.2.2. Systemic Lupus Erythematosus (SLE); 7.2.3. Scleroderma; 7.2.4. Vasculitis; 7.2.5. Inflammatory Bowel Disease (IBD); 7.2.6. Others; 7.3. Market Analysis, Insights and Forecast – By Test Type; 7.3.1. Antinuclear Autoantibody (ANA); 7.3.2. Rheumatoid Factor (RF); 7.3.3. C-Reactive Protein (CRP); 7.3.4. Anti-Thyroglobulin Antibody (ATA); 7.3.5. Others; 7.4. Market Analysis, Insights and Forecast – By End User; 7.4.1. Hospital & Clinics; 7.4.2. Diagnostic Centers; 7.4.3. Others; 7.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 7.5.1. U.K.; 7.5.2. Germany; 7.5.3. France; 7.5.4. Italy; 7.5.5. Spain; 7.5.6. Rest of Europe
8. Asia Pacific Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2019-2030: 8.1. Market Analysis, Insights and Forecast – By Product Type; 8.1.1. Instruments; 8.1.2. Reagents & Consumables; 8.2. Market Analysis, Insights and Forecast – By Disease Type; 8.2.1. Rheumatoid Arthritis (RA); 8.2.2. Systemic Lupus Erythematosus (SLE); 8.2.3. Scleroderma; 8.2.4. Vasculitis; 8.2.5. Inflammatory Bowel Disease (IBD); 8.2.6. Others; 8.3. Market Analysis, Insights and Forecast – By Test Type; 8.3.1. Antinuclear Autoantibody (ANA); 8.3.2. Rheumatoid Factor (RF); 8.3.3. C-Reactive Protein (CRP); 8.3.4. Anti-Thyroglobulin Antibody (ATA); 8.3.5. Others; 8.4. Market Analysis, Insights and Forecast – By End User; 8.4.1. Hospital & Clinics; 8.4.2. Diagnostic Centers; 8.4.3. Others; 8.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 8.5.1. Japan; 8.5.2. China; 8.5.3. India; 8.5.4. Australia; 8.5.5. Rest of Asia Pacific
9. Rest of the World Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2019-2030: 9.1. Market Analysis, Insights and Forecast – By Product Type; 9.1.1. Instruments; 9.1.2. Reagents & Consumables; 9.2. Market Analysis, Insights and Forecast – By Disease Type; 9.2.1. Rheumatoid Arthritis (RA); 9.2.2. Systemic Lupus Erythematosus (SLE); 9.2.3. Scleroderma; 9.2.4. Vasculitis; 9.2.5. Inflammatory Bowel Disease (IBD); 9.2.6. Others; 9.3. Market Analysis, Insights and Forecast – By Test Type; 9.3.1. Antinuclear Autoantibody (ANA); 9.3.2. Rheumatoid Factor (RF); 9.3.3. C-Reactive Protein (CRP); 9.3.4. Anti-Thyroglobulin Antibody (ATA); 9.3.5. Others; 9.4. Market Analysis, Insights and Forecast – By End User; 9.4.1. Hospital & Clinics; 9.4.2. Diagnostic Centers; 9.4.3. Others
10. Competitive Analysis: 10.1. Global Market Share Analysis (2022); 10.2. Company Profiles; 10.2.1. Siemens Healthcare GmbH; 10.2.1.1. Overview; 10.2.1.2. Product; 10.2.1.3. SWOT Analysis; 10.2.1.4. Recent Developments; 10.2.1.5. Strategies; 10.2.1.6. financials (Based on Availability); 10.2.2. Thermo Fisher Scientific Inc.; 10.2.2.1. Overview; 10.2.2.2. Product; 10.2.2.3. SWOT Analysis; 10.2.2.4. Recent Developments; 10.2.2.5. Strategies; 10.2.2.6. financials (Based on Availability); 10.2.3. Quest Diagnostics Incorporated; 10.2.3.1. Overview; 10.2.3.2. Product; 10.2.3.3. SWOT Analysis; 10.2.3.4. Recent Developments; 10.2.3.5. Strategies; 10.2.3.6. financials (Based on Availability); 10.2.4. Abbott; 10.2.4.1. Overview; 10.2.4.2. Product; 10.2.4.3. SWOT Analysis; 10.2.4.4. Recent Developments; 10.2.4.5. Strategies; 10.2.4.6. financials (Based on Availability); 10.2.5. Werfen; 10.2.5.1. Overview; 10.2.5.2. Product; 10.2.5.3. SWOT Analysis; 10.2.5.4. Recent Developments; 10.2.5.5. Strategies; 10.2.5.6. financials (Based on Availability); 10.2.6. Trinity Biotech; 10.2.6.1. Overview; 10.2.6.2. Product; 10.2.6.3. SWOT Analysis; 10.2.6.4. Recent Developments; 10.2.6.5. Strategies; 10.2.6.6. financials (Based on Availability); 10.2.7. F. Hoffmann-La Roche Ltd; 10.2.7.1. Overview; 10.2.7.2. Product; 10.2.7.3. SWOT Analysis; 10.2.7.4. Recent Developments; 10.2.7.5. Strategies; 10.2.7.6. financials (Based on Availability); 10.2.8. Bio-Rad Laboratories, Inc.; 10.2.8.1. Overview; 10.2.8.2. Product; 10.2.8.3. SWOT Analysis; 10.2.8.4. Recent Developments; 10.2.8.5. Strategies; 10.2.8.6. financials (Based on Availability)

U.S. Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Test Type, By End-use, And Segment Forecasts, 2024 - 2030

May, 2024 | Published by: Grand View Research | USD $5,950
Sexually Transmitted Diseases Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

June, 2024 | Published by: Fortune Business Insights Pvt. Ltd. | USD $4,850
Autoimmune Disease Diagnosis Market Report by Product Type (Consumables and Assay Kits, Instruments), Disease Type (Systemic Autoimmune Disease, Localized Autoimmune Disease), Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies and Immunologic Tests, and Others), End-User (Clinical Laboratories, Hospitals. and Others), and Region 2024-2032

August, 2024 | Published by: IMARC Services Pvt. Ltd. | USD $3,899
Autoimmune Disease Diagnosis Market Size, Trends, Analysis, and Outlook By Disease (Systemic Autoimmune Disease, Localized Autoimmune Disease), By Diagnosis (Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), C-reactive Protein (CRP), Urinalysis, Others), by Country, Segment, and Companies, 2024-2032

April, 2024 | Published by: VPA Research | USD $3,980
Autoimmune Disease Diagnostics Market Analysis and Forecast to 2031: By Disease Type (Systemic Autoimmune Disease, Localized Autoimmune Disease), Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-reactive Protein (CRP), Complete Blood Count (CBC), Urinalysis, Others), End-user (Hospitals, Diagnostics Centers, Others), and Region

November, 2022 | Published by: Global Insight Services | USD $4,750
Autoimmune Disease Diagnostics Market Size By Disease Type (Systemic Autoimmune Disease {Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Psoriasis, Multiple Sclerosis}, Localized Autoimmune Disease {Inflammatory Bowel Disease, Type 1 Diabetes, Thyroid}), By Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-reactive Protein (CRP), Complete Blood Count (CBC), Urinalysis), By End-use (Hospitals, Diagnostics Centers), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Application Potential, Competitive Market Share & Forecast, 2022 - 2030

July, 2022 | Published by: Global Market Insights | USD $5,150

PDF E-mail From Publisher:	$4,850
Global Site License Fulfilled by Publisher:	$6,850

Autoimmune Disease Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032